Author Archive: AZBio
Banner Alzheimer’s Institute celebrates 20 years of pioneering research, compassionate care
Two decades of groundbreaking discoveries in prevention, treatment & detectionContinue reading
Janko Z. Nikolich, MD, PhD, Honored as Regents Professor at the U of A’s 2026 Luminaries Outstanding Faculty Awards
The awards showcased the extraordinary talent shaping the future of science, arts, innovation and education at the University of ArizonaContinue reading
BIO Unveils Seven-Point Plan to Secure America’s Leadership in the Biotech Century
Action plan outlines the policies needed to ensure that the biotechnology sector remains a driving force for America’s health, prosperity, national security, and geopolitical strengthContinue reading
BD Names Bridget Bagnato Worldwide President of Peripheral Intervention
FRANKLIN LAKES, N.J., Nov. 4, 2026 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Bridget Bagnato has been appointed worldwide president of its Peripheral Intervention business unit, effective November 16.
Based at Peripheral Intervention’s headquarters in Tempe, Arizona, Bagnato will be responsible for driving the business unit’s global strategic, operational and commercial performance. She will report to Peter Menziuso, executive vice president and president of the Interventional segment.Continue reading
CMS Publishes Final Rule on Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
In August 2o26, the Arizona Bioindustry Association (AZBio) joined over 11,ooo stakeholders from across the country in submitting comments on the CMS Proposed Rule on Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program. On November 5, 2026, CMS published the final rule. Continue reading
BIO, Biocom, and California Life Sciences Sue to Block CMS GLOBE Rule
Complaint argues HHS and CMS exceeded statutory authority; rule puts patient access, investment in future innovation, and America’s long-term biotechnology leadership at risk.Continue reading
TGen Scientists Use AlphaFold3 to Predict Complex Immune Interactions
New AI-driven approach could help researchers better understand how the immune system responds to infections and cancer
Arizona Bioscience on the Rise: Highlights from the 2026 TEConomy/BIO Report
Arizona’s bioscience industry isn’t just growing. It’s outpacing the nation.
The 2026 edition of The U.S. Bioscience Economy from TEConomy Partners and the Biotechnology Innovation Organization (BIO) gives us a fresh look at how Arizona stacks up. The short version: since 2021, our bioscience workforce has grown 13.4 percent, nearly twice the national rate of 7.0 percent. Here’s what’s driving that momentum.Continue reading
U.S. Bioscience Industry Powers Over $3 Trillion in Economic Output, New Report Finds
WASHINGTON, DC (October 28, 2026) – Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry’s economic impact.